SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000908834-22-000085
Filing Date
2022-02-11
Accepted
2022-02-11 13:04:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 13ga1_caribou.htm SC 13G/A 388938
  Complete submission text file 0000908834-22-000085.txt   390552
Mailing Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA SUITE 2100 SAN FRANCISCO CA 94111 (415)421-2132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Subject) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92726 | Film No.: 22618863
SIC: 2836 Biological Products, (No Diagnostic Substances)